FIGURE 1.
A comparison of traditional de novo drug discovery and development versus drug repurposing. The translation gap (“valley of death”) describes the problem of translation of basic scientific findings in a laboratory setting into human applications and potential treatments (Butler, 2008; Gamo et al., 2017). Drug repurposing reduces this gap and thus the time, risk, and investment associated with the development of new therapies.